|
Monday, April 7th 2013: For immediate release
For the purposes of this report, the phrase ‘corporate reputation’ is defined as the extent to which pharma companies are meeting the expectations of patients and patient groups.
In January 2013, PatientView published ‘The Corporate Reputation of Pharma—the Patient Perspective', based on the opinions of 600 patient groups worldwide. PatientView is now releasing four reports on the performance of major pharma companies in Germany, Italy, UK and USA.
Surprisingly, the corporate reputation of pharma, and the rankings of each of the pharma companies, varies significantly between the four countries.
BELOW ARE THE NUMBERS OF RESPONDENT PATIENT GROUPS IN EACH COUNTRY—AND THE COMPANIES ANALYSED IN EACH COUNTRY REPORT
|
|
|
|
GERMANY:
70 patient groups polled. Company rankings provided for 15 companies: Abbott [AbbVie], AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-MyersSquibb, Lilly, GSK, Janssen, Merck & Co, Merck Group, Novartis, Pfizer, Roche, Sanofi, Stada Arzneimittel
|
|
|
|
|
|
ITALY:
30 patient groups polled. Company rankings provided for 9 companies: Abbott [AbbVie], AstraZeneca, Bayer, GSK, Menarini, Novartis, Pfizer, Roche, Sanofi
|
|
|
|
|
|
UK:
80 patient groups polled. Company rankings provided for 12 companies: Abbott [AbbVie], AstraZeneca, Bayer, Boehringer Ingelheim, Lilly, GSK, Janssen, Merck & Co, Novartis, Pfizer, Roche, Sanofi
|
|
|
|
|
|
USA:
70 patient groups polled. Company rankings provided for 11 companies: Abbott [AbbVie], AstraZeneca, Bayer, Bristol-Myers Squibb, Lilly, GSK, Merck & Co, Novartis, Pfizer, Roche
|
|
|
Key findings on the status of pharma reputation during 2012
In 2012, 40% of 600 respondent patient groups believed that the corporate reputation of pharma had declined worldwide. However, patient groups' attitude to pharma varies significantly across the four countries analysed.
Pharma in the USA stands out as worst among the four countries:
-
63% of respondent US patient groups believe that the corporate reputation of the pharma industry declined in 2012
-
40% of respondent UK patient groups believe that the corporate reputation of the pharma industry declined in 2012
-
37% of respondent Italian patient groups believe that the corporate reputation of the pharma industry declined in 2012
-
33% of respondent German patient groups believe that the corporate reputation of the pharma industry declined in 2012
|
|
Few healthcare industries have a worse reputation than pharma. But, in Italy and Germany, generic and biotech companies have a worse reputation than pharma (respectively)
Industries faring worse than pharma for corporate reputation:
• Worldwide, 34% of respondent patient groups state that pharma had an excellent or good reputation in 2012. For-profit health insurers fared worse, with just 24% of respondents stating the same.
• In Germany, 30% of respondent patient groups state that pharma had an excellent or good reputation in 2012. For-profit health insurers fared worse, with just 28% of respondents stating the same. However, as few as 27% of the respondent patient groups state that biotechnology companies had an excellent or good reputation.
• In Italy, as many as 52% of respondent patient groups state that pharma had an excellent or good reputation in 2012. For-profit health insurers fared worse, with just 21% of respondents stating the same. However, only 40% of the respondent patient groups also state that generic companies have an excellent or good reputation.
|
|
Top pharma performers for 2012
Companies ranking top for corporate reputation in the different countries:
-
Germany: Janssen
-
Italy: Pfizer
-
UK: Pfizer
-
USA: Bayer
Please click on the following links to obtain further details about each country report:
Germany
Italy
UK
USA
|
|
Contact details
If you have any further queries, please contact, Alexandra Wyke, CEO, PatientView.
Email address: report@patient-view.com
Landline telephone: 0044-(0)1547-520-965
Information on the press coverage of the global version of the 'Corporate Reputation' report can be found at the PatientView blog: http://patientview.posterous.com/
|
|
|
|
|